1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 18 JANUARY 2016

Cancer Drug News 18 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Celgene Continues On Rapid Growth Trajectory
Industry Brief - CFDA Accepts For Review CASI's Import Drug Registration Application For Marqibo
Industry Brief - Venetoclax Granted FDA Priority Reveiw
Industry Trend Analysis - Lenvima Has Small Window Of Opportunity In RCC
Industry Brief - Exelixis Seeks EU Approval For Cabozantinib In Advanced RCC
Industry Brief - Sorrento Biosimilars Show Positive Phase III Results
Industry Brief - BioLineRx/Merck Enter Clinical Collaboration Agreement
Industry Brief - DelMar/MD Anderson Collaborate To Advance VAL-083 Development In GBM
Industry Brief - OncoFusion Reacquires Rights To BET Bromodomain Inhibitors
Industry Brief - Loxo's LOXO-101 Gains EU Orphan Designation For Soft Tissue Sarcoma
Industry Brief - QIAGEN Enters Master Collaboration For CDx With Array BioPharma
Industry Trend Analysis - Anti-PD-1/PD-L1 Development Will Reach Maximum Intensity In 2016
Industry Brief - Novartis Signs Immuno-Oncology Pact With Surface Oncology
Industry Brief - AstraZeneca Partners To Develop Immuno-Oncology mRNA Therapeutics
Industry Brief - Sloan Kettering/Juno To Co-Develop Fully-Human MUC16 Binder In CAR T-Cell Immunotherapy
Industry Brief - Merck Acquires IOmet Pharma
Industry Brief - Juno Adds Next-Generation Single Cell Sequencing Platform Through AbVitro Acquisition
Industry Trend Analysis - Roche Building Capacity To Front Next Generation Epigenetic Drug Development

Table Of Contents

Cancer Drug News 18 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.